Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors

Detalles Bibliográficos
Autores principales: Kowalczyk, Aleksandra, Huber, Stephan, Heidenreich, Regina, Fotin-Mleczek, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288395/
http://dx.doi.org/10.1186/2051-1426-2-S3-P109
_version_ 1782351963187314688
author Kowalczyk, Aleksandra
Huber, Stephan
Heidenreich, Regina
Fotin-Mleczek, Mariola
author_facet Kowalczyk, Aleksandra
Huber, Stephan
Heidenreich, Regina
Fotin-Mleczek, Mariola
author_sort Kowalczyk, Aleksandra
collection PubMed
description
format Online
Article
Text
id pubmed-4288395
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42883952015-01-15 Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors Kowalczyk, Aleksandra Huber, Stephan Heidenreich, Regina Fotin-Mleczek, Mariola J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288395/ http://dx.doi.org/10.1186/2051-1426-2-S3-P109 Text en Copyright © 2014 Kowalczyk et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Kowalczyk, Aleksandra
Huber, Stephan
Heidenreich, Regina
Fotin-Mleczek, Mariola
Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
title Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
title_full Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
title_fullStr Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
title_full_unstemmed Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
title_short Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
title_sort self-adjuvanted rnactive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288395/
http://dx.doi.org/10.1186/2051-1426-2-S3-P109
work_keys_str_mv AT kowalczykaleksandra selfadjuvantedrnactivevaccinesprovideapromisingplatformforcombinationtherapieswithcheckpointinhibitors
AT huberstephan selfadjuvantedrnactivevaccinesprovideapromisingplatformforcombinationtherapieswithcheckpointinhibitors
AT heidenreichregina selfadjuvantedrnactivevaccinesprovideapromisingplatformforcombinationtherapieswithcheckpointinhibitors
AT fotinmleczekmariola selfadjuvantedrnactivevaccinesprovideapromisingplatformforcombinationtherapieswithcheckpointinhibitors

Ejemplares similares